A promising research on cancer treatment will be presented to investors
The technology from MUNI was chosen for Academic Innovators presentation at BIO-Europe Spring 2019. Our researcher Vítězslav Bryja is going to speak about promising research of highly potent and selective inhibitors of CK1 kinases for the treatment of leukemias, lymphomas and solid tumors. TTO MUNI is looking for a research partner and a licensee for this technology.
TTO MUNI again hosted internships for Tech Transfer colleagues
A total of 24 trainees took part in the internship
Save the Date and Enter the World of our Spin-offs
We will launch the registration and publish the detailed program during September.
Trademark “Tested in Antarctica” Given to Clothes and Insulating Materials
Six more products received a quality label
"The Stand from the Future" entertained festival visitors
Nine thousand people visited MUNI 100 Festival